The implications of this study demonstrating the role of PPARγ in the probiotic- and synbiotic-mediated benefits in AD is that it expands the potential mechanisms of GBA communication and provide a potential clinical targets that could be relevant in chronic diseases that can be modulated by the gut microbiota. This evidence concerns the gene PPARG and Alzheimer disease.